FIELD: biochemistry.
SUBSTANCE: invention relates to compounds of Formula (I):
in which R1 is selected from a group consisting of H, 
R2 is selected from a group consisting of H, 
R3 is H, 
or 
; wherein two of R1, R2 and R3 are H, and one of R1, R2 and R3 differs from H, or its pharmacologically acceptable salts modulating C5a receptor. Pharmaceutical compositions containing such compounds and treatment methods are also described.
EFFECT: compounds and pharmaceutical compositions containing such compounds can be used in medicine.
25 cl, 2 dwg, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND INTERMEDIATES IN PRODUCING C5aR ANTAGONISTS | 2015 |
|
RU2712233C2 |
| PYRIDYL-PIPERIDINE ANTAGONISTS OF OREXIN RECEPTORS | 2008 |
|
RU2470021C2 |
| AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
| MODULATORS CCR2 | 2016 |
|
RU2726206C2 |
| GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811403C2 |
| PRODRUGS OF PYRIDONAMIDES USED AS MODULATORS OF SODIUM CHANNELS | 2014 |
|
RU2692766C1 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2681211C2 |
| IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
| PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
